Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Qsymia published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-4 of 4
» View wsbt.com items only
    Dec 5, 2012 |Story| Chicago Tribune
  1. Weigh pros and cons of 2 new diet drugs

    Weight-loss drugs have so far been a complete bust. But they may be verging on a comeback, now that the Food and Drug Administration has approved two new prescription diet pills for the first time in more than a decade.
    Weight-loss drugs have so far been a complete bust. But they may be verging on a comeback, now that the Food and Drug Administration has approved two new prescription diet pills for the first time in more than a decade. Both weight-loss medications...

    Tags: Phentermine (drug), George Washington University, Mouth, Physical Conditions, Overweight

  2. Jul 17, 2012 |Story| CNN
  3. Jun 27, 2012 |Story| Los Angeles Times
  4. FDA approves lorcaserin, first weight-loss drug since 1999

    The Food and Drug Administration has approved marketing of the weight-loss drug lorcaserin, the first prescription anti-obesity medication to win the FDA's blessing since the agency approved orlistat in 1999.
    The Food and Drug Administration has approved marketing of the weight-loss drug lorcaserin, the first prescription anti-obesity medication to win the FDA's blessing since the agency approved orlistat in 1999. Once it is cleared by the Drug Enforcement...

    Tags: Weight Loss, Phentermine (drug), Contrave (drug), Massachusetts General Hospital, Overweight

  5. Mar 29, 2012 |Story| Reuters
  6. Obesity drugs need heart studies, U.S. advisers say

    SILVER SPRING, Maryland (Reuters) - Heart safety studies should be required for new obesity drugs, U.S. drug advisers said on Thursday, possibly adding a new hurdle to the drugs' approval.
    Reuters
    SILVER SPRING, Maryland (Reuters) - Heart safety studies should be required for new obesity drugs, U.S. drug advisers said on Thursday, possibly adding a new hurdle to the drugs' approval. An advisory panel to the U.S. Food and Drug Administration...

    Tags: Weight Loss, Trials, Contrave (drug), Health, Economy, Business and Finance

Original site for Qsymia topic gallery.